Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia

Journal of the Saudi Heart Association

Volumn 24, Issue 2, 2012, Pages 99-121

  Maharaj, R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anaesthesia; Diabetes; Diastolic dysfunction; HF with preserved ejection fraction; Paediatrics; Renal; Sepsis

Indexed keywords

ALDOSTERONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CANRENONE; DIURETIC AGENT; IRBESARTAN; IVABRADINE; LEVOSIMENDAN; NITRATE; PERINDOPRIL; PLACEBO; SPIRONOLACTONE;

AGING; ANESTHESIA; CARDIOMYOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRRHOTIC CARDIOMYOPATHY; CRITICAL ILLNESS; DIABETES MELLITUS; DIASTOLE; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; ECHOCARDIOGRAPHY; EXERCISE; EXTRACELLULAR MATRIX; HEART DISEASE; HEART EJECTION FRACTION; HEART MUSCLE CELL; HUMAN; KIDNEY DISEASE; PATHOPHYSIOLOGY; PEDIATRICS; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPSIS; SYSTOLIC HEART FAILURE;

EID: 84859866363     PISSN: 10167315     EISSN: 22125043     Source Type: Journal    
DOI: 10.1016/j.jsha.2012.01.004     Document Type: Review

References (259)

1. Rackow E.C., Kaufman B.S., Falk J.L., Astiz M.E., Weil M.H. Hemodynamic response to fluid repletion in patients with septic shock: evidence for early depression of cardiac performance. Circ Shock 1987, 22:11-22.
2. Farias S., Powers F.M., Law W.R. End-diastolic pressure-volume relationship in sepsis: relative contributions of compliance and equilibrium chamber volume differ. J Sur Res 1999, 82:172-179.
3. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171.
4. Cleland J.G., Cohen-Solal A., Aguilar J.C., Dietz R., Eastaugh J., Follath F., Freemantle N., Gavazzi A., van Gilst W.H., Hobbs F.D., et al. Management of HF in primary care (the IMPROVEMENT of HF programme): an international survey. Lancet 2002, 360:1631-1639.
5. Haldeman G.A., Croft J.B., Giles W.H., Rashidee A. Hospitalization of patients with HF: national hospital discharge survey, 1985 to 1995. Am Heart J 1999, 137:352-360.
6. Aurigemma G.P., Gaasch W.H. Clinical practice. Diastolic HF. N Engl J Med 2004, 351:1097-1105.
7. Kitzman D.W. Diastolic dysfunction in the elderly. Genesis and diagnostic and therapeutic implications. Cardiol Clin 2000, 18:597-617. [x].
8. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive HF in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948-1955.
9. Aurigemma G.P., Gottdiener J.S., Shemanski L., Gardin J., Kitzman D. Predictive value of systolic and diastolic function for incident congestive HF in the elderly: the cardiovascular health study. J Am Coll Cardiol 2001, 37:1042-1048.
10. Hogg K., Swedberg K., McMurray J. HF with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004, 43:317-327.
11. Thomas M.D., Fox K.F., Coats A.J., Sutton G.C. The epidemiological enigma of HF with preserved systolic function. Eur J Heart Fail 2004, 6:125-136.
12. Owan T.E., Redfield M.M. Epidemiology of diastolic HF. Prog Cardiovasc Dis 2005, 47:320-332.
13. Ergina P.L., Gold S.L., Meakins J.L. Perioperative care of the elderly patient. World J Surg 1993, 17:192-198.
14. Kessler KM. Diastolic HF. Diagnosis and management. Hospital practice 1989 [Office ed. 24, 137-141, 146-138, 158-160 passim].
15. Zile M.R., Baicu C.F., Bonnema D.D. Diastolic HF: definitions and terminology. Prog Cardiovasc Dis 2005, 47:307-313.
16. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic HF. Eur Heart J 2001, 22:1527-1560.
17. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., Francis G.S., Ganiats T.G., Goldstein S., Gregoratos G., Jessup M.L., et al. ACC/AHA guidelines for the evaluation and management of chronic HF in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 guidelines for the evaluation and management of HF): developed in collaboration with the international society for heart and lung transplantation; endorsed by the HF Society of America. Circulation 2001, 104:2996-3007.
18. Zile M.R. HF with preserved ejection fraction: is this diastolic HF?. J Am Coll Cardiol 2003, 41:1519-1522.
19. Vasan R.S., Levy D. Defining diastolic HF: a call for standardized diagnostic criteria. Circulation 2000, 101:2118-2121.
20. Paulus W.J. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 1998, 19:990-1003.
21. Dao Q., Krishnaswamy P., Kazanegra R., Harrison A., Amirnovin R., Lenert L., Clopton P., Alberto J., Hlavin P., Maisel A.S. Utility of B-type natriuretic peptide in the diagnosis of congestive HF in an urgent-care setting. J Am Coll Cardiol 2001, 37:379-385.
22. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., Gardetto N., Wanner E., Maisel A.S. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105:595-601.
23. Yamaguchi H., Yoshida J., Yamamoto K., Sakata Y., Mano T., Akehi N., Hori M., Lim Y.J., Mishima M., Masuyama T. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic HF independent of ventricular hypertrophy. J Am Coll Cardiol 2004, 43:55-60.
24. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003, 108:2987-2992.
25. Sabatine M.S., Morrow D.A., de Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., Hall C., McCabe C.H., Braunwald E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004, 44:1988-1995.
26. Goetze J.P., Christoffersen C., Perko M., Arendrup H., Rehfeld J.F., Kastrup J., Nielsen L.B. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003, 17:1105-1107.
27. Yturralde R.F., Gaasch W.H. Diagnostic criteria for diastolic HF. Prog Cardiovasc Dis 2005, 47:314-319.
28. Zile M.R., Gaasch W.H., Carroll J.D., Feldman M.D., Aurigemma G.P., Schaer G.L., Ghali J.K., Liebson P.R. HF with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic HF?. Circulation 2001, 104:779-782.
29. Paulus W.J., Tschope C., Sanderson J.E., Rusconi C., Flachskampf F.A., Rademakers F.E., Marino P., Smiseth O.A., De Keulenaer G., Leite-Moreira A.F., et al. How to diagnose diastolic HF: a consensus statement on the diagnosis of HF with normal left ventricular ejection fraction by the HF and echocardiography associations of the European Society of Cardiology. Eur Heart J 2007, 28:2539-2550.
30. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., Waggoner A.D., Flachskampf F.A., Pellikka P.A., Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009, 22:107-133.
31. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic HF: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105:1387-1393.
32. Groban L. Diastolic dysfunction in the older heart. J Cardiothorac Vasc Anesth 2005, 19:228-236.
33. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic HF: part II: causal mechanisms and treatment. Circulation 2002, 105:1503-1508.
34. Apstein C.S. Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial. Circulation 1998, 98:2223-2226.
35. Kass D.A., Solaro R.J. Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation 2006, 113:305-315.
36. Solaro R.J., Rarick H.M. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 1998, 83:471-480.
37. Solaro R.J. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res 1999, 84:122-124.
38. McDonough J.L., Arrell D.K., Van Eyk J.E. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 1999, 84:9-20.
39. 2+ exchanger protein levels in human HF. Circulation 1999, 99:2105-2112.
40. +]i handling in the failing human heart. Cardiovasc Res 2003, 57:874-886.
41. 2+ exchanger in end-stage failing human myocardium. Eur Heart J 2002, 23:1118-1124.
42. Hasenfuss G., Pieske B. Calcium cycling in congestive HF. J Mol Cell Cardiol 2002, 34:951-969.
43. + channels. J Clin Invest 2006, 116:3127-3138.
44. Ingwall J.S. Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol 2004, 37:613-623.
45. Solaro R.J., Rosevear P., Kobayashi T. The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun 2008, 369:82-87.
46. Alpert N.R., Mulieri L.A., Warshaw D. The failing human heart. Cardiovasc Res 2002, 54:1-10.
47. Tian R., Nascimben L., Ingwall J.S., Lorell B.H. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation 1997, 96:1313-1319.
48. Zile M.R., Richardson K., Cowles M.K., Buckley J.M., Koide M., Cowles B.A., Gharpuray V., Cooper G.t. Constitutive properties of adult mammalian cardiac muscle cells. Circulation 1998, 98:567-579.
49. Borlaug B.A., Kass D.A. Mechanisms of diastolic dysfunction in HF. Trends Cardiovasc Med 2006, 16:273-279.
50. Kostin S., Hein S., Arnon E., Scholz D., Schaper J. The cytoskeleton and related proteins in the human failing heart. HF Reviews 2000, 5:271-280.
51. Bell S.P., Nyland L., Tischler M.D., McNabb M., Granzier H., LeWinter M.M. Alterations in the determinants of diastolic suction during pacing tachycardia. Circ Res 2000, 87:235-240.
52. Tagawa H., Wang N., Narishige T., Ingber D.E., Zile M.R., Cooper G.t. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy. Circ Res 1997, 80:281-289.
53. Zile M.R., Cowles M.K., Buckley J.M., Richardson K., Cowles B.A., Baicu C.F., Cooper G.I., Gharpuray V. Gel stretch method: a new method to measure constitutive properties of cardiac muscle cells. Am J Physiol 1998, 274:H2188-H2202.
54. Granzier H., Labeit S. Cardiac titin: an adjustable multi-functional spring. J Physiol 2002, 541:335-342.
55. Katz A.M., Zile M.R. New molecular mechanism in diastolic HF. Circulation 2006, 113:1922-1925.
56. Cazorla O., Freiburg A., Helmes M., Centner T., McNabb M., Wu Y., Trombitas K., Labeit S., Granzier H. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ Res 2000, 86:59-67.
57. van Heerebeek L., Borbely A., Niessen H.W., Bronzwaer J.G., van der Velden J., Stienen G.J., Linke W.A., Laarman G.J., Paulus W.J. Myocardial structure and function differ in systolic and diastolic HF. Circulation 2006, 113:1966-1973.
58. Selby D.E., Palmer B.M., LeWinter M.M., Meyer M. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol 2011, 58:147-154.
59. Libby P., Lee R.T. Matrix matters. Circulation 2000, 102:1874-1876.
60. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849-1865.
61. Weber K.T., Sun Y., Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994, 23:869-877.
62. Covell J.W. Factors influencing diastolic function. Possible role of the extracellular matrix. Circulation 1990, 81:III155-III158.
63. Ross R.S., Borg T.K. Integrins and the myocardium. Circ Res 2001, 88:1112-1119.
64. Spinale F.G., Coker M.L., Bond B.R., Zellner J.L. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res 2000, 46:225-238.
65. Ahmed S.H., Clark L.L., Pennington W.R., Webb C.S., Bonnema D.D., Leonardi A.H., McClure C.D., Spinale F.G., Zile M.R. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006, 113:2089-2096.
66. Kim H.E., Dalal S.S., Young E., Legato M.J., Weisfeldt M.L., D'Armiento J. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 2000, 106:857-866.
67. Martos R., Baugh J., Ledwidge M., O'Loughlin C., Conlon C., Patle A., Donnelly S.C., McDonald K. Diastolic HF: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007, 115:888-895.
68. Baghelai K., Marktanner R., Dattilo J.B., Dattilo M.P., Jakoi E.R., Yager D.R., Makhoul R.G., Wechsler A.S. Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium. J Surg Res 1998, 77:35-39.
69. Greene J., Wang M., Liu Y.E., Raymond L.A., Rosen C., Shi Y.E. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996, 271:30375-30380.
70. Fedak P.W., Verma S., Weisel R.D., Li R.K. Cardiac remodeling and failure From molecules to man (Part II). Cardiovasc Pathol 2005, 14:49-60.
71. Froehlich J.P., Lakatta E.G., Beard E., Spurgeon H.A., Weisfeldt M.L., Gerstenblith G. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J Mol Cell Cardiol 1978, 10:427-438.
72. Cain B.S., Meldrum D.R., Joo K.S., Wang J.F., Meng X., Cleveland J.C., Banerjee A., Harken A.H. Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol 1998, 32:458-467.
73. Schmidt U., del Monte F., Miyamoto M.I., Matsui T., Gwathmey J.K., Rosenzweig A., Hajjar R.J. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 2000, 101:790-796.
74. Assayag P., Davies C.H., Marty I., de Leiris J., Lompre A.M., Boucher F., Valere P.E., Lortet S., Swynghedauw B., Besse S. Effects of sustained low-flow ischemia on myocardial function and calcium-regulating proteins in adult and senescent rat hearts. Cardiovasc Res 1998, 38:169-180.
75. Lakatta E.G., Sollott S.J. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol 2002, 132:699-721.
76. Davies C.H., Ferrara N., Harding S.E. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovasc Res 1996, 31:152-156.
77. White M., Roden R., Minobe W., Khan M.F., Larrabee P., Wollmering M., Port J.D., Anderson F., Campbell D., Feldman A.M., et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994, 90:1225-1238.
78. Feldman R.D., Limbird L.E., Nadeau J., Robertson D., Wood A.J. Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med 1984, 310:815-819.
79. Kitzman D.W., Scholz D.G., Hagen P.T., Ilstrup D.M., Edwards W.D. Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 1988, 63:137-146.
80. Rooke G.A. Cardiovascular aging and anesthetic implications. J Cardiothorac Vasc Anesth 2003, 17:512-523.
81. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a " set up" for vascular disease. Circulation 2003, 107:139-146.
82. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
83. Matz R.L., Schott C., Stoclet J.C., Andriantsitohaina R. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res/Acad Sci Bohemoslov 2000, 49:11-18.
84. Kawaguchi M., Hay I., Fetics B., Kass D.A. Combined ventricular systolic and arterial stiffening in patients with HF and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107:714-720.
85. Kelly R.P., Tunin R., Kass D.A. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res 1992, 71:490-502.
86. Pepe S., Lakatta E.G. Aging hearts and vessels: masters of adaptation and survival. Cardiovasc Res 2005, 66:190-193.
87. Cook C.H., Praba A.C., Beery P.R., Martin L.C. Transthoracic echocardiography is not cost-effective in critically ill surgical patients. J Trauma 2002, 52:280-284.
88. Vignon P., Mentec H., Terre S., Gastinne H., Gueret P., Lemaire F. Diagnostic accuracy and therapeutic impact of transthoracic and transesophageal echocardiography in mechanically ventilated patients in the ICU. Chest 1994, 106:1829-1834.
89. Groban L., Dolinski S.Y. Transesophageal echocardiographic evaluation of diastolic function. Chest 2005, 128:3652-3663.
90. Skarvan K., Zuber M., Seeberger M., Stulz P. Immediate effects of mitral valve replacement on left ventricular function and its determinants. Eur J Anaesthesiol 1999, 16:590-599.
91. Filipovic M., Michaux I., Wang J., Hunziker P., Skarvan K., Seeberger M. Effects of sevoflurane and propofol on left ventricular diastolic function in patients with pre-existing diastolic dysfunction. Br J Anaesth 2007, 98:12-18.
92. Filipovic M., Wang J., Michaux I., Hunziker P., Skarvan K., Seeberger M.D. Effects of halothane, sevoflurane and propofol on left ventricular diastolic function in humans during spontaneous and mechanical ventilation. Br J Anaesth 2005, 94:186-192.
93. Matyal R., Skubas N.J., Shernan S.K., Mahmood F. Perioperative assessment of diastolic dysfunction. Anesth Analg 2011, 113:449-472.
94. Tabata T., Thomas J.D., Klein A.L. Pulmonary venous flow by Doppler echocardiography: revisited 12 years later. J Am Coll Cardiol 2003, 41:1243-1250.
95. Klein A.L., Tajik A.J. Doppler assessment of pulmonary venous flow in healthy subjects and in patients with heart disease. J Am Soc Echocardiogr 1991, 4:379-392.
96. Maclaren G., Kluger R., Prior D., Royse A., Royse C. Tissue Doppler, strain, and strain rate echocardiography: principles and potential perioperative applications. J Cardiothorac Vasc Anesth 2006, 20:583-593.
97. Sanderson J.E., Wang M., Yu C.M. Tissue Doppler imaging for predicting outcome in patients with cardiovascular disease. Curr Opin Cardiol 2004, 19:458-463.
98. Nikitin N.P., Witte K.K. Application of tissue Doppler imaging in cardiology. Cardiology 2004, 101:170-184.
99. Sutherland G.R., Kukulski T., Voight J.U., D'Hooge J. Tissue Doppler echocardiography: future developments. Echocardiography (Mount Kisco, NY) 2000, 16:509-520.
100. D'Hooge J., Heimdal A., Jamal F., Kukulski T., Bijnens B., Rademakers F., Hatle L., Suetens P., Sutherland G.R. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 2000, 1:154-170.
101. Pislaru C., Abraham T.P., Belohlavek M. Strain and strain rate echocardiography. Curr Opin Cardiol 2002, 17:443-454.
102. Gorcsan J., Tanaka H. Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 2011, 58:1401-1413.
103. Mor-Avi V., Lang R.M., Badano L.P., Belohlavek M., Cardim N.M., Derumeaux G., Galderisi M., Marwick T., Nagueh S.F., Sengupta P.P., et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 2011, 24:277-313.
104. Senni M., Redfield M.M. HF with preserved systolic function. A different natural history?. J Am Coll Cardiol 2001, 38:1277-1282.
105. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., Krumholz H.M. Outcomes in HF patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003, 41:1510-1518.
106. Cohn J.N., Johnson G. HF with normal ejection fraction. The V-HeFT study. Veterans administration cooperative study group. Circulation 1990, 81:III48-III53.
107. East M.A., Peterson E.D., Shaw L.K., Gattis W.A., O'Connor C.M. Racial differences in the outcomes of patients with diastolic HF. Am Heart J 2004, 148:151-156.
108. Ansari M., Alexander M., Tutar A., Massie B.M. Incident cases of HF in a community cohort: importance and outcomes of patients with preserved systolic function. Am Heart J 2003, 146:115-120.
109. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Gong Y., Liu P.P. Outcome of HF with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
110. Ahmed A., Perry G.J., Fleg J.L., Love T.E., Goff D.C., Kitzman D.W. Outcomes in ambulatory chronic systolic and diastolic HF: a propensity score analysis. Am Heart J 2006, 152:956-966.
111. Malki Q., Sharma N.D., Afzal A., Ananthsubramaniam K., Abbas A., Jacobson G., Jafri S. Clinical presentation, hospital length of stay, and readmission rate in patients with HF with preserved and decreased left ventricular systolic function. Clin Cardiol 2002, 25:149-152.
112. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the HF epidemic. JAMA 2003, 289:194-202.
113. Perez de Isla L., Canadas V., Contreras L., Almeria C., Rodrigo J.L., Aubele A.L., Mataix L., Herrera D., Serra V., Zamorano J. Diastolic HF in the elderly: in-hospital and long-term outcome after the first episode. Int J Cardiol 2008.
114. Wang M., Yip G.W., Wang A.Y., Zhang Y., Ho P.Y., Tse M.K., Lam P.K., Sanderson J.E. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003, 41:820-826.
115. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E.L., Fleischmann K.E., Freeman W.K., Froehlich J.B., Kasper E.K., Kersten J.R., et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009, 120:e169-e276.
116. Poldermans D., Bax J.J., Boersma E., De Hert S., Eeckhout E., Fowkes G., et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009, 30:2769-2812. The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).
117. Goldman L., Caldera D.L., Nussbaum S.R., Southwick F.S., Krogstad D., Murray B., Burke D.S., O'Malley T.A., Goroll A.H., Caplan C.H., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977, 297:845-850.
118. Detsky A.S., Abrams H.B., McLaughlin J.R., Drucker D.J., Sasson Z., Johnston N., Scott J.G., Forbath N., Hilliard J.R. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986, 1:211-219.
119. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., Sugarbaker D.J., Donaldson M.C., Poss R., Ho K.K., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999, 100:1043-1049.
120. Levy W.C., Mozaffarian D., Linker D.T., Sutradhar S.C., Anker S.D., Cropp A.B., Anand I., Maggioni A., Burton P., Sullivan M.D., et al. The Seattle HF Model: prediction of survival in HF. Circulation 2006, 113:1424-1433.
121. Vazquez R., Bayes-Genis A., Cygankiewicz I., Pascual-Figal D., Grigorian-Shamagian L., Pavon R., Gonzalez-Juanatey J.R., Cubero J.M., Pastor L., Ordonez-Llanos J., et al. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic HF. Eur Heart J 2009, 30:1088-1096.
122. Senni M., Santilli G., Parrella P., De Maria R., Alari G., Berzuini C., Scuri M., Filippi A., Migliori M., Minetti B., et al. A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with HF. Am J Cardiol 2006, 98:1076-1082.
123. Perry G.J., Ahmed M.I., Desai R.V., Mujib M., Zile M., Sui X., Aban I.B., Zhang Y., Tallaj J., Allman R.M., et al. Left ventricular diastolic function and exercise capacity in community-dwelling adults >/=65 years of age without HF. Am J Cardiol 2011, 108:735-740.
124. Auerbach A., Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006, 113:1361-1376.
125. Reilly D.F., McNeely M.J., Doerner D., Greenberg D.L., Staiger T.O., Geist M.J., Vedovatti P.A., Coffey J.E., Mora M.W., Johnson T.R., et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999, 159:2185-2192.
126. Kitzman D.W. Exercise intolerance. Prog Cardiovasc Dis 2005, 47:367-379.
127. Frenneaux M., Williams L. Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. Prog Cardiovasc Dis 2007, 49:252-262.
128. Kitzman D.W., Higginbotham M.B., Cobb F.R., Sheikh K.H., Sullivan M.J. Exercise intolerance in patients with HF and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065-1072.
129. Libonati J.R., Colby A.M., Caldwell T.M., Kasparian R., Glassberg H.L. Systolic and diastolic cardiac function time intervals and exercise capacity in women. Med Sci Sports Exerc 1999, 31:258-263.
130. Haykowsky M.J., Brubaker P.H., John J.M., Stewart K.P., Morgan T.M., Kitzman D.W. Determinants of exercise intolerance in elderly HF patients with preserved ejection fraction. J Am Coll Cardiol 2011, 58:265-274.
131. Phillip B., Pastor D., Bellows W., Leung J.M. The prevalence of pre-operative diastolic filling abnormalities in geriatric surgical patients. Anesth Analg 2003, 97:1214-1221.
132. Matyal R., Hess P.E., Subramaniam B., Mitchell J., Panzica P.J., Pomposelli F., Mahmood F. Perioperative diastolic dysfunction during vascular surgery and its association with post-operative outcome. J Vasc Surg 2009, 50:70-76.
133. Couture P., Denault A.Y., Shi Y., Deschamps A., Cossette M., Pellerin M., Tardif J.C. Effects of anesthetic induction in patients with diastolic dysfunction. Can J Anaesth 2009, 56:357-365.
134. Mahmood F., Matyal R., Subramaniam B., Mitchell J., Pomposelli F., Lerner A.B., Maslow A., Hess P.M. Transmitral flow propagation velocity and assessment of diastolic function during abdominal aortic aneurysm repair. J Cardiothorac Vasc Anesth 2007, 21:486-491.
135. Vaskelyte J., Stoskute N., Kinduris S., Ereminiene E. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: predictive significance of left ventricular diastolic filling pattern. Eur J Echocardiogr 2001, 2:62-67.
136. Denault A.Y., Couture P., Buithieu J., Haddad F., Carrier M., Babin D., Levesque S., Tardif J.C. Left and right ventricular diastolic dysfunction as predictors of difficult separation from cardiopulmonary bypass. Can J Anaesth 2006, 53:1020-1029.
137. Bernard F., Denault A., Babin D., Goyer C., Couture P., Couturier A., Buithieu J. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg 2001, 92:291-298.
138. Marui A., Nishina T., Saji Y., Yamazaki K., Shimamoto T., Ikeda T., Sakata R. Significance of left ventricular diastolic function on outcomes after surgical ventricular restoration. Annal Thora Surg 2010, 89:1524-1531.
139. Gelsomino S., Lorusso R., Bille G., Rostagno C., De Cicco G., Romagnoli S., Porciani C., Tetta C., Stefano P., Gensini G.F. Left ventricular diastolic function after restrictive mitral ring annuloplasty in chronic ischemic mitral regurgitation and its predictive value on outcome and recurrence of regurgitation. Int J Cardiol 2009, 132:419-428.
140. Hogg K., McMurray J. The treatment of HF with preserved ejection fraction (" diastolic HF" ). HF reviews 2006, 11:141-146.
141. Osranek M., Fatema K., Qaddoura F., Al-Saileek A., Barnes M.E., Bailey K.R., Gersh B.J., Tsang T.S., Zehr K.J., Seward J.B. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol 2006, 48:779-786.
142. Houltz B., Johansson B., Berglin E., Karlsson T., Edvardsson N., Wandt B. Left ventricular diastolic function and right atrial size are important rhythm outcome predictors after intraoperative ablation for atrial fibrillation. Echocardiography (Mount Kisco, NY) 2010, 27:961-968.
143. Patti G., Chello M., Candura D., Pasceri V., D'Ambrosio A., Covino E., Di Sciascio G. Randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006, 114:1455-1461.
144. Mahmud A., Feely J. Arterial stiffness and the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst 2004, 5:102-108.
145. Vanhecke T.E., Kim R., Raheem S.Z., McCullough P.A. Myocardial ischemia in patients with diastolic dysfunction and HF. Curr Cardiol Rep 2010, 12:216-222.
146. Balci B., Yilmaz O. Influence of left ventricular geometry on regional systolic and diastolic function in patients with essential hypertension. Scand Cardiovasc J 2002, 36:292-296.
147. Neuhauser C., Muller M., Welters I., Scholz S., Kwapisz M.M. Effect of isoflurane on echocardiographic left-ventricular relaxation indices in patients with diastolic dysfunction due to concentric hypertrophy and ischemic heart disease. J Cardiothorac Vasc Anesth 2006, 20:509-514.
148. Pagel P.S., Hettrick D.A., Kersten J.R., Lowe D., Warltier D.C. Cardiovascular effects of propofol in dogs with dilated cardiomyopathy. Anesthesiology 1998, 88:180-189.
149. Sprung J., Ogletree-Hughes M.L., McConnell B.K., Zakhary D.R., Smolsky S.M., Moravec C.S. The effects of propofol on the contractility of failing and nonfailing human heart muscles. Anesth Analg 2001, 93:550-559.
150. Kanaya N., Gable B., Murray P.A., Damron D.S. Propofol increases phosphorylation of troponin I and myosin light chain 2 via protein kinase C activation in cardiomyocytes. Anesthesiology 2003, 98:1363-1371.
151. Sarkar S., GuhaBiswas R., Rupert E. Echocardiographic evaluation and comparison of the effects of isoflurane, sevoflurane and desflurane on left ventricular relaxation indices in patients with diastolic dysfunction. Annal Card Anaesth 2010, 13:30-137.
152. Gare M., Parail A., Milosavljevic D., Kersten J.R., Warltier D.C., Pagel P.S. Conscious sedation with midazolam or propofol does not alter left ventricular diastolic performance in patients with preexisting diastolic dysfunction: a transmitral and tissue Doppler transthoracic echocardiography study. Anesth Analg 2001, 93:865-871.
153. Moores W.Y., Weiskopf R.B., Baysinger M., Utley J.R. Effects of halothane and morphine sulfate on myocardial compliance following total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981, 81:163-170.
154. Bolliger D., Seeberger M.D., Kasper J., Skarvan K., Seeberger E., Lurati Buse G., Buser P., Filipovic M. Remifentanil does not impair left ventricular systolic and diastolic function in young healthy patients. Br J Anaesth 2011, 106:573-579.
155. Blanco J., Muriel-Bombin A., Sagredo V., Taboada F., Gandia F., Tamayo L., et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care (London, England) 2008, 12:R158.
156. Parker M.M., Shelhamer J.H., Bacharach S.L., Green M.V., Natanson C., Frederick T.M., Damske B.A., Parrillo J.E. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100:483-490.
157. Parker M.M., McCarthy K.E., Ognibene F.P., Parrillo J.E. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990, 97:126-131.
158. Ognibene F.P., Parker M.M., Natanson C., Shelhamer J.H., Parrillo J.E. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988, 93:903-910.
159. Jafri S.M., Lavine S., Field B.E., Bahorozian M.T., Carlson R.W. Left ventricular diastolic function in sepsis. Crit Care Med 1990, 18:709-714.
160. Munt B., Jue J., Gin K., Fenwick J., Tweeddale M. Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 1998, 26:1829-1833.
161. Baitugaeva G.A., Lukach V.N., Dolgikh V.T., Govorova N.V., Glushchenko A.V. Diastolic malfunction in sepsis and septic shock. Anesteziol Reanimatol 2004, 47-49.
162. Soble J.S. Doppler " diastology" : a new twist to the study of sepsis. Crit Care Med 1998, 26:1777-1778.
163. Voyce S.J., Becker R.C. Adaptive and maladaptive cardiovascular responses in human sepsis. Am Heart J 1991, 122:1441-1448.
164. Poelaert J., Declerck C., Vogelaers D., Colardyn F., Visser C.A. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997, 23:553-560.
165. Raper R.F., Sibbald W.J., Hobson J., Neal A., Cheung H. Changes in myocardial blood flow rates during hyperdynamic sepsis with induced changes in arterial perfusing pressures and metabolic need. Crit Care Med 1993, 21:1192-1199.
166. Barraud D., Faivre V., Damy T., Welschbillig S., Gayat E., Heymes C., Payen D., Shah A.M., Mebazaa A. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 2007, 35:1376-1382.
167. Tavernier B., Li J.M., El-Omar M.M., Lanone S., Yang Z.K., Trayer I.P., Mebazaa A., Shah A.M. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J 2001, 15:294-296.
168. Schmitz L., Xanthopoulos A., Koch H., Lange P.E. Doppler flow parameters of left ventricular filling in infants: how long does it take for the maturation of the diastolic function in a normal left ventricle to occur?. Pediatr Cardiol 2004, 25:482-491.
169. Mori K., Nakagawa R., Nii M., Edagawa T., Takehara Y., Inoue M., Kuroda Y. Pulsed wave Doppler tissue echocardiography assessment of the long axis function of the right and left ventricles during the early neonatal period. Heart (British Cardiac Society) 2004, 90:175-180.
170. Schmitz L., Stiller B., Pees C., Koch H., Xanthopoulos A., Lange P. Doppler-derived parameters of diastolic left ventricular function in preterm infants with a birth weight <1500 g: reference values and differences to term infants. Early Human Dev 2004, 76:101-114.
171. Schmitz L., Stiller B., Koehne P., Koch H., Lange P.E. Doppler echocardiographic investigation of left ventricular diastolic function in preterm infants with and without a patent ductus arteriosus. Klin Padiatr 2004, 216:36-40.
172. Eidem B.W., McMahon C.J., Cohen R.R., Wu J., Finkelshteyn I., Kovalchin J.P., Ayres N.A., Bezold L.I., O'Brian Smith E., Pignatelli R.H. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J Am Soc Echocardiogr 2004, 17:212-221.
173. Giardini A., Moore P., Brook M., Stratton V., Tacy T. Effect of transcatheter atrial septal defect closure in children on left ventricular diastolic function. Am J Cardiol 2005, 95:1255-1257.
174. Gomez C.A., Ludomirsky A., Ensing G.J., Rocchini A.P. Effect of acute changes in load on left ventricular diastolic function during device closure of atrial septal defects. Am J Cardiol 2005, 95:686-688.
175. Hanseus K.C., Bjorkhem G.E., Brodin L.A., Pesonen E. Analysis of atrioventricular plane movements by Doppler tissue imaging and M-mode in children with atrial septal defects before and after surgical and device closure. Pediatr Cardiol 2002, 23:152-159.
176. Eyskens B., Ganame J., Claus P., Boshoff D., Gewillig M., Mertens L. Ultrasonic strain rate and strain imaging of the right ventricle in children before and after percutaneous closure of an atrial septal defect. J Am Soc Echocardiogr 2006, 19:994-1000.
177. Weber M., Dill T., Deetjen A., Neumann T., Ekinci O., Hansel J., Elsaesser A., Mitrovic V., Hamm C. Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients. Heart (British Cardiac Society) 2006, 92:671-675.
178. Celik S., Ozay B., Dagdeviren B., Gorgulu S., Yildirim A., Uslu N., Ketenci B., Eren M., Akgoz H., Demirtas M., et al. Effect of patient age at surgical intervention on long-term right ventricular performance in atrial septal defect. Jpn Heart J 2004, 45:265-273.
179. Cullen S., Shore D., Redington A. Characterization of right ventricular diastolic performance after complete repair of tetralogy of Fallot. Restrictive physiology predicts slow post-operative recovery. Circulation 1995, 91:1782-1789.
180. Gatzoulis M.A., Norgard G., Redington A.N. Biventricular long axis function after repair of tetralogy of Fallot. Pediatr Cardiol 1998, 19:128-132.
181. Rathore K.S., Gupta N., Kapoor A., Modi N., Singh P.K., Tewari P., Sinha N. Assessment of right ventricular diastolic function: does it predict post-operative course in tetralogy of Fallot. Indian Heart J 2004, 56:220-224.
182. Sachdev M.S., Bhagyavathy A., Varghese R., Coelho R., Kumar R.S. Right ventricular diastolic function after repair of tetralogy of Fallot. Pediatr Cardiol 2006, 27:250-255.
183. Toyono M., Harada K., Tamura M., Yamamoto F., Takada G. Myocardial acceleration during isovolumic contraction as a new index of right ventricular contractile function and its relation to pulmonary regurgitation in patients after repair of tetralogy of Fallot. J Am Soc Echocardiogr 2004, 17:332-337.
184. Yasuoka K., Harada K., Toyono M., Tamura M., Yamamoto F. Tei index determined by tissue Doppler imaging in patients with pulmonary regurgitation after repair of tetralogy of Fallot. Pediatr Cardiol 2004, 25:131-136.
185. Solarz D.E., Witt S.A., Glascock B.J., Jones F.D., Khoury P.R., Kimball T.R. Right ventricular strain rate and strain analysis in patients with repaired tetralogy of Fallot: possible interventricular septal compensation. J Am Soc Echocardiogr 2004, 17:338-344.
186. Frommelt P.C. Echocardiographic measures of diastolic function in pediatric heart disease. Curr Opin Cardiol 2006, 21:194-199.
187. Chaturvedi R.R., Shore D.F., Lincoln C., Mumby S., Kemp M., Brierly J., Petros A., Gutteridge J.M., Hooper J., Redington A.N. Acute right ventricular restrictive physiology after repair of tetralogy of Fallot: association with myocardial injury and oxidative stress. Circulation 1999, 100:1540-1547.
188. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., Laragh J.H. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
189. Shlipak M.G., Smith G.L., Rathore S.S., Massie B.M., Krumholz H.M. Renal function, digoxin therapy, and HF outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol 2004, 15:2195-2203.
190. Ahmed A., Kiefe C.I., Allman R.M., Sims R.V., DeLong J.F. Survival benefits of angiotensin-converting enzyme inhibitors in older HF patients with perceived contraindications. J Am Geriatr Soc 2002, 50:1659-1666.
191. McAlister F.A., Ezekowitz J., Tonelli M., Armstrong P.W. Renal insufficiency and HF: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004, 109:1004-1009.
192. Mitsnefes M.M., Kimball T.R., Border W.L., Witt S.A., Glascock B.J., Khoury P.R., Daniels S.R. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 2004, 65:1461-1466.
193. Mitsnefes M.M., Kathman T.S., Mishra J., Kartal J., Khoury P.R., et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol (Berlin, Germany) 2007, 22:101-108.
194. Mitsnefes M.M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol (Berlin, Germany) 2008, 23:27-39.
195. Ahmed A., Rich M.W., Sanders P.W., Perry G.J., Bakris G.L., Zile M.R., Love T.E., Aban I.B., Shlipak M.G. Chronic kidney disease associated mortality in diastolic versus systolic HF: a propensity matched study. Am J Cardiol 2007, 99:393-398.
196. Garg R., Gorlin R., Smith T., Yusuf S. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997, 336:525-533.
197. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of HF with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
198. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 2006, 48:1548-1551.
199. Bella J.N., Devereux R.B., Roman M.J., Palmieri V., Liu J.E., Paranicas M., Welty T.K., Lee E.T., Fabsitz R.R., Howard B.V. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001, 87:1260-1265.
200. Shishehbor M.H., Hoogwerf B.J., Schoenhagen P., Marso S.P., Sun J.P., Li J., Klein A.L., Thomas J.D., Garcia M.J. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol 2003, 91(1514-1517):A1519.
201. Poornima I.G., Parikh P., Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006, 98:596-605.
202. Bertoni A.G., Tsai A., Kasper E.K., Brancati F.L. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 2003, 26:2791-2795.
203. Di Carli M.F., Janisse J., Grunberger G., Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003, 41:1387-1393.
204. Srinivasan M., Herrero P., McGill J.B., Bennik J., Heere B., Lesniak D., Davila-Roman V.G., Gropler R.J. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2005, 46:42-48.
205. Rigo F., Richieri M., Pasanisi E., Cutaia V., Zanella C., Della Valentina P., Di Pede F., Raviele A., Picano E. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 2003, 91:269-273.
206. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., Anversa P. Myocardial cell death in human diabetes. Circ Res 2000, 87:1123-1132.
207. Quinones M.J., Hernandez-Pampaloni M., Schelbert H., Bulnes-Enriquez I., Jimenez X., Hernandez G., De La Rosa R., Chon Y., Yang H., Nicholas S.B., et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med 2004, 140:700-708.
208. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005, 109:143-159.
209. Pop-Busui R., Kirkwood I., Schmid H., Marinescu V., Schroeder J., Larkin D., Yamada E., Raffel D.M., Stevens M.J. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004, 44:2368-2374.
210. Bidasee K.R., Nallani K., Yu Y., Cocklin R.R., Zhang Y., Wang M., Dincer U.D., Besch H.R. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 2003, 52:1825-1836.
211. Candido R., Forbes J.M., Thomas M.C., Thallas V., Dean R.G., Burns W.C., Tikellis C., Ritchie R.H., Twigg S.M., Cooper M.E., et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 2003, 92:785-792.
212. McNulty P.H. Insulin resistance and cardiac mass: the end of the beginning?. Obes Res 2003, 11:507-508.
213. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171-176.
214. Birnbaum M.J. Turning down insulin signaling. J Clin Invest 2001, 108:655-659.
215. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001, 108:437-446.
216. Sasso F.C., Carbonara O., Cozzolino D., Rambaldi P., Mansi L., Torella D., Gentile S., Turco S., Torella R., Salvatore T. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. J Am Coll Cardiol 2000, 36:219-226.
217. Huikuri H.V., Airaksinen J.K., Lilja M., Takkunen J.T. Echocardiographic evaluation of left ventricular response to isometric exercise in young insulin-dependent diabetics. Acta Diabetol Lat 1986, 23:193-200.
218. Dagres N., Saller B., Haude M., Husing J., von Birgelen C., Schmermund A., Sack S., Baumgart D., Mann K., Erbel R. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol 2004, 61:724-731.
219. Macnee W., Maclay J., McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:824-833.
220. Barr R.G., Bluemke D.A., Ahmed F.S., Carr J.J., Enright P.L., Hoffman E.A., Jiang R., Kawut S.M., Kronmal R.A., Lima J.A., et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010, 362:217-227.
221. Sabit R., Bolton C.E., Fraser A.G., Edwards J.M., Edwards P.H., Ionescu A.A., Cockcroft J.R., Shale D.J. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 2010, 104:1171-1178.
222. Mancini G.B., Etminan M., Zhang B., Levesque L.E., FitzGerald J.M., Brophy J.M. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006, 47:2554-2560.
223. Huiart L., Ernst P., Ranouil X., Suissa S. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 2005, 25:634-639.
224. Soyseth V., Brekke P.H., Smith P., Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007, 29:279-283.
225. Moller S., Henriksen J.H. Cirrhotic cardiomyopathy. J Hepatol 2010, 53:179-190.
226. Ma Z., Lee S.S. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology (Baltimore, MD) 1996, 24:451-459.
227. Schmieder R.E. Salt intake is related to the process of myocardial hypertrophy in essential hypertension. JAMA 1989, 262:1187-1188.
228. Pozzi M., Carugo S., Boari G., Pecci V., de Ceglia S., Maggiolini S., Bolla G.B., Roffi L., Failla M., Grassi G., et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology (Baltimore, MD) 1997, 26:1131-1137.
229. Cazzaniga M., Salerno F., Pagnozzi G., Dionigi E., Visentin S., Cirello I., Meregaglia D., Nicolini A. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007, 56:869-875.
230. Rabie R.N., Cazzaniga M., Salerno F., Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009, 104:2458-2466.
231. Torregrosa M., Aguade S., Dos L., Segura R., Gonzalez A., Evangelista A., Castell J., Margarit C., Esteban R., Guardia J., et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005, 42:68-74.
232. Powell BP, De Keulenaer B. Levosimendan: a new option in acute septic cardiac failure? Emerg Med Australas 2007; 19: 177 [author reply 177-8].
233. Petrie M.C., Caruana L., Berry C., McMurray J.J. " Diastolic HF" or HF caused by subtle left ventricular systolic dysfunction?. Heart (British Cardiac Society) 2002, 87:29-31.
234. Vinereanu D., Nicolaides E., Tweddel A.C., Fraser A.G. " Pure" diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of HF. Eur J Heart Fail 2005, 7:820-828.
235. Brutsaert D.L., De Keulenaer G.W. Diastolic HF: a myth. Curr Opin Cardiol 2006, 21:240-248.
236. Zile M.R., Lewinter M.M. Left ventricular end-diastolic volume is normal in patients with HF and a normal ejection fraction: a renewed consensus in diastolic HF. J Am Coll Cardiol 2007, 49:982-985.
237. Neagoe C., Kulke M., del Monte F., Gwathmey J.K., de Tombe P.P., Hajjar R.J., Linke W.A. Titin isoform switch in ischemic human heart disease. Circulation 2002, 106:1333-1341.
238. Borbely A., van der Velden J., Papp Z., Bronzwaer J.G., Edes I., Stienen G.J., Paulus W.J. Cardiomyocyte stiffness in diastolic HF. Circulation 2005, 111:774-781.
239. Maeder M.T., Kaye D.M. HF with normal left ventricular ejection fraction. J Am Coll Cardiol 2009, 53:905-918.
240. Rhoney D., Peacock W.F. Intravenous therapy for hypertensive emergencies, part 2. Am J Health Syst Pharm 2009, 66:1448-1457.
241. Rhoney D., Peacock W.F. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm 2009, 66:1343-1352.
242. Peter J.V., Moran J.L., Phillips-Hughes J., Graham P., Bersten A.D. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 2006, 367:1155-1163.
243. Bendjelid K., Schutz N., Suter P.M., Fournier G., Jacques D., Fareh S., Romand J.A. Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction?. Chest 2005, 127:1053-1058.
244. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
245. Tamaki S., Sakata Y., Mano T., Ohtani T., Takeda Y., Kamimura D., Omori Y., Yamamoto K. Long-term beta-blocker therapy improves diastolic function even without the therapeutic effect on systolic function in patients with reduced ejection fraction. J Cardiol 2010, 56:176-182.
246. Farasat S.M., Bolger D.T., Shetty V., Menachery E.P., Gerstenblith G., Kasper E.K., Najjar S.S. Effect of Beta-blocker therapy on rehospitalization rates in women versus men with HF and preserved ejection fraction. Am J Cardiol 2010, 105:229-234.
247. Swedberg K., Komajda M., Bohm M., Borer J.S., Ford I., Tavazzi L. Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic HF: the Systolic HF Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT). Eur J Heart Fail 2010, 12:75-81.
248. Izawa H., Murohara T., Nagata K., Isobe S., Asano H., Amano T., Ichihara S., Kato T., Ohshima S., Murase Y., et al. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 2005, 112:2940-2945.
249. Grandi A.M., Imperiale D., Santillo R., Barlocco E., Bertolini A., Guasti L., Venco A. Aldosterone antagonist improves diastolic function in essential hypertension. Hypertension 2002, 40:647-652.
250. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., Michelson E.L., Olofsson B., Ostergren J. Effects of candesartan in patients with chronic HF and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777-781.
251. Cleland J.G., Tendera M., Adamus J., Freemantle N., Polonski L., Taylor J. The perindopril in elderly people with chronic HF (PEP-CHF) study. Eur Heart J 2006, 27:2338-2345.
252. Massie B.M., Carson P.E., McMurray J.J., Komajda M., McKelvie R., Zile M.R., Anderson S., Donovan M., Iverson E., Staiger C., et al. Irbesartan in patients with HF and preserved ejection fraction. N Engl J Med 2008, 359:2456-2467.
253. Matejovic M., Krouzecky A., Radej J., Novak I. Successful reversal of resistent hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 2005, 49:127-128.
254. Morelli A., Teboul J.L., Maggiore S.M., Vieillard-Baron A., Rocco M., Conti G., De Gaetano A., Picchini U., Orecchioni A., Carbone I., et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006, 34:2287-2293.
255. Morelli A., De Castro S., Teboul J.L., Singer M., Rocco M., Conti G., De Luca L., Di Angelantonio E., Orecchioni A., Pandian N.G., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005, 31:638-644.
256. Landoni G., Mizzi A., Biondi-Zoccai G., Bignami E., Prati P., Ajello V., Marino G., Guarracino F., Zangrillo A. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol 2010, 76:276-286.
257. Paulus W.J., van Ballegoij J.J. Treatment of HF with normal ejection fraction: an inconvenient truth!. J Am Coll Cardiol 2010, 55:526-537.
258. Senni M., Tribouilloy C.M., Rodeheffer R.J., Jacobsen S.J., Evans J.M., Bailey K.R., Redfield M.M. Congestive HF in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98:2282-2289.
259. Gabriel R.S., Klein A.L. Modern evaluation of left ventricular diastolic function using Doppler echocardiography. Curr Cardiol Rep 2009, 11:231-238.